scPharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Rhea-AI Summary

scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company specializing in optimized delivery of infused therapies, has announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference. John Tucker, the company's President & CEO, is scheduled to present on Wednesday, September 11 at 10:00AM ET.

In addition to the presentation, Mr. Tucker will be engaging in investor meetings throughout the day. Interested parties can access a webcast of the presentation via a provided link or through the 'News & Events' section of scPharmaceuticals' official website.

This event provides an opportunity for scPharmaceuticals to showcase its progress in developing products aimed at advancing patient care and reducing healthcare costs through innovative infusion therapy delivery methods.

BURLINGTON, Mass., Sept. 04, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, President & Chief Executive Officer, will present at the H.C. Wainwright 26^th Annual Global Investment Conference on Wednesday, September 11 at 10:00AM ET. Mr. Tucker will also be meeting with investors that day.

A webcast of the presentation can be accessed here or under “News & Events” in the Investor Relations section of the Company’s website, www.scPharmaceuticals.com.

About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

Katherine Miranda
scPharmaceuticals Inc., 781-301-6869
kmiranda@scpharma.com

Investors:
PJ Kelleher
LifeSci Advisors, 617-430-7579
pkelleher@lifesciadvisors.com

FAQ

When is scPharmaceuticals (SCPH) presenting at the H.C. Wainwright Global Investment Conference?

scPharmaceuticals (SCPH) is presenting at the H.C. Wainwright 26th Annual Global Investment Conference on Wednesday, September 11 at 10:00AM ET.

Who will be presenting for scPharmaceuticals (SCPH) at the investment conference?

John Tucker, the President & Chief Executive Officer of scPharmaceuticals (SCPH), will be presenting at the investment conference.

How can investors access the scPharmaceuticals (SCPH) presentation at the H.C. Wainwright conference?

Investors can access a webcast of the scPharmaceuticals (SCPH) presentation through a provided link or under the 'News & Events' section in the Investor Relations area of the company's website, www.scPharmaceuticals.com.

What is the focus of scPharmaceuticals (SCPH) as a company?

scPharmaceuticals (SCPH) focuses on developing and commercializing products that optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs.